EyeGate Pharmaceuticals, Inc. Gains 22.95%
Thu, Sep 30, 2021 at 05:30 PM
EyeGate Pharmaceuticals, Inc. (EYEG:NASDAQ) rocketted at $2.25, representing a gain of 23%. On Wed, Sep 29, 2021, EYEG:NASDAQ hit a New 2-Week Intraday Low of $1.76. The stock appeared on our News Catalysts scanner on Thu, Sep 09, 2021 at 04:46 PM in the 'MISCELLANEOUS' category. From Wed, Sep 15, 2021, the stock recorded 50.00% Up Days and 36.36% Green Days
The stock spiked on Tue, Jul 27, 2021 at $6.43 with a volume of 50M+.
About EyeGate Pharmaceuticals, Inc. (EYEG:NASDAQ)
Eyegate Pharmaceuticals Inc is a clinical-stage specialty pharmaceutical company. The Company is engaged in developing and commercializing products for treating diseases and disorders of the eye.
Top 10 Gainers:
- Conyers Park II Acquisition Corp. (CPAA:NASDAQ), 100%
- Superior Drilling Products, Inc. (SDPI:NYSEMKT), 60.55%
- PROG (PROG:NASDAQ), 40.74%
- Farmmi, Inc. (FAMI:NASDAQ), 36.03%
- ALZN (ALZN:NASDAQ), 35.09%
- OG (OG:NYSE), 30%
- Aeterna Zentaris Inc. (AEZS:NASDAQ), 25.63%
- EyeGate Pharmaceuticals, Inc. (EYEG:NASDAQ), 22.95%
- Mediaco Holding Inc. (MDIA:NASDAQ), 20.08%
- Epsilon Energy Ltd. (EPSN:NASDAQ), 18.38%